Difference between revisions of "Team:KCL UK/Safety"
| Line 2: | Line 2: | ||
<html> | <html> | ||
<head> | <head> | ||
| − | + | <link href="https://fonts.googleapis.com/css?family=Raleway" rel="stylesheet"> | |
<meta charset="UTF-8"> | <meta charset="UTF-8"> | ||
| Line 11: | Line 11: | ||
<style> | <style> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
#top_title {display:none;} | #top_title {display:none;} | ||
| Line 31: | Line 25: | ||
} | } | ||
| − | #content, #HQ_page | + | #HQ_page h1,h2,h3 { |
| + | font-family: 'Raleway', sans-serif; | ||
| + | font-weight: 300; | ||
| + | } | ||
| + | |||
| + | #content, #HQ_page { | ||
animation : none; | animation : none; | ||
animation-delay : 0; | animation-delay : 0; | ||
| Line 107: | Line 106: | ||
float : none; | float : none; | ||
font : normal; | font : normal; | ||
| − | font-family : | + | font-family: 'Raleway', sans-serif; |
font-size : medium; | font-size : medium; | ||
font-style : normal; | font-style : normal; | ||
| Line 183: | Line 182: | ||
h1 { | h1 { | ||
| − | |||
display: block; | display: block; | ||
font-size: 2em; | font-size: 2em; | ||
| Line 190: | Line 188: | ||
margin-left: 0; | margin-left: 0; | ||
margin-right: 0; | margin-right: 0; | ||
| − | |||
} | } | ||
| Line 214: | Line 211: | ||
font-family: 'Raleway', sans-serif; | font-family: 'Raleway', sans-serif; | ||
} | } | ||
| − | |||
| − | |||
| − | |||
body{ | body{ | ||
| Line 413: | Line 407: | ||
color: #FF0000; | color: #FF0000; | ||
position: relative; | position: relative; | ||
| − | margin-top: - | + | margin-top: -5em; |
margin-bottom: 3em; | margin-bottom: 3em; | ||
background: black; | background: black; | ||
| Line 420: | Line 414: | ||
width: 35vw; | width: 35vw; | ||
text-align: center; | text-align: center; | ||
| + | |||
} | } | ||
.home-about-textbox a { | .home-about-textbox a { | ||
Revision as of 21:22, 8 October 2018
what are we doing?
We are developing a new technology platform based on 3'UTR sequence characterisation to control soluble protein expression in E.coli.
We will use E.coli K12 to test our "Proof of Concept" Principle by engineering 3'UTR sequences (Sharma et al, 2011) to interact with either cytosolic proteins or 5'UTR sequences of our gene of interest: trxA and gor. Down regulation of these genes will be quantified by assessing quantitatively GFP signal. Efficiency of down regulation of genes will be quantified by assessing reaction kinetics of Alkaline Phosphatase (AP).
Some of Our Work
iGEM Symposium
See More
Bexley School Visit
See More
Social Media
See More
Lab Work
See More